Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yulia Lin

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Transfusion|January 12, 2021
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysisJacob Pendergrast, Chantal Armali, Jeannie Callum, et al.
Haematologica|February 29, 2020
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopeniaPeter A A Norris, George B Segel, W Richard Burack, et al.
British Journal of Haematology|January 22, 2020
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trialSimon J Stanworth, Sally Killick, Zoe K McQuilten, et al.
International Journal of Laboratory Hematology|January 5, 2023
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi studyKanza Naveed, Nicola Goldberg, Eliane Shore, et al.
Anesthesiology|January 29, 2025
Tranexamic Dosing for Major Joint Arthroplasty in Adult Patients with Chronic Kidney Disease: A Pharmacokinetic Study and New Dosing RegimenQi Yang, Jim He, H Benson Peng, et al.
Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
Transfusion|February 11, 2021
Multicenter observational study evaluating the impact of platelet transport bags on product wastageAmie Kron, Shangari Vijenthira, Jacob Pendergrast, et al.
The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.
BMJ Open|February 25, 2022
Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trialPaul Jack Karanicolas, Yulia Lin, Stuart McCluskey, et al.
American Journal of Hematology|December 21, 2023
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studiesRena Buckstein, Jeannie Callum, Anca Prica, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Transfusion|January 12, 2021
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysisJacob Pendergrast, Chantal Armali, Jeannie Callum, et al.
Haematologica|February 29, 2020
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopeniaPeter A A Norris, George B Segel, W Richard Burack, et al.
British Journal of Haematology|January 22, 2020
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trialSimon J Stanworth, Sally Killick, Zoe K McQuilten, et al.
International Journal of Laboratory Hematology|January 5, 2023
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi studyKanza Naveed, Nicola Goldberg, Eliane Shore, et al.
Anesthesiology|January 29, 2025
Tranexamic Dosing for Major Joint Arthroplasty in Adult Patients with Chronic Kidney Disease: A Pharmacokinetic Study and New Dosing RegimenQi Yang, Jim He, H Benson Peng, et al.
Cancer Genetics and Cytogenetics|September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factorsYulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
Transfusion|February 11, 2021
Multicenter observational study evaluating the impact of platelet transport bags on product wastageAmie Kron, Shangari Vijenthira, Jacob Pendergrast, et al.
The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.
BMJ Open|February 25, 2022
Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trialPaul Jack Karanicolas, Yulia Lin, Stuart McCluskey, et al.
American Journal of Hematology|December 21, 2023
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studiesRena Buckstein, Jeannie Callum, Anca Prica, et al.
Pageof 18